Cargando…
From Genetic Mutations to Molecular Basis of Heart Failure Treatment: An Overview of the Mechanism and Implication of the Novel Modulators for Cardiac Myosin
Heart failure (HF) is a syndrome encompassing several important etiologies that lead to the imbalance between oxygen demand and supply. Despite the usage of guideline-directed medical therapy for HF has shown better outcomes, novel therapeutic strategies are desirable, especially for patients with p...
Autores principales: | Chen, Yu-Jen, Chien, Chian-Shiu, Chiang, Chern-En, Chen, Chen-Huan, Cheng, Hao-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234187/ https://www.ncbi.nlm.nih.gov/pubmed/34205587 http://dx.doi.org/10.3390/ijms22126617 |
Ejemplares similares
-
Cardiac Myosin Binding Protein C and MAP-Kinase Activating Death Domain-Containing Gene Polymorphisms and Diastolic Heart Failure
por: Wu, Cho-Kai, et al.
Publicado: (2012) -
Modulation of myosin by cardiac myosin binding protein-C peptides improves cardiac contractility in ex-vivo experimental heart failure models
por: Hou, Luqia, et al.
Publicado: (2022) -
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil
por: Kaplinsky, Edgardo, et al.
Publicado: (2018) -
Nocturnal thoracic volume overload and post‐discharge outcomes in patients hospitalized for acute heart failure
por: Chang, Hao‐Chih, et al.
Publicado: (2020) -
Prognostic Role of Pulmonary Function in Patients With Heart Failure With Reduced Ejection Fraction
por: Chang, Hao‐Chih, et al.
Publicado: (2022)